Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.9900-0.0097 (-0.97%)
At close: 03:59PM EST
1.0200 +0.03 (+3.03%)
After hours: 06:15PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.9997
Open0.9500
Bid0.9900 x 1800
Ask1.0200 x 1400
Day's Range0.9500 - 1.0200
52 Week Range0.8980 - 2.5800
Volume28,407
Avg. Volume57,023
Market Cap20.79M
Beta (5Y Monthly)1.63
PE Ratio (TTM)N/A
EPS (TTM)-1.3570
Earnings DateNov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FBRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Forte Biosciences, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
Advertisement
Advertisement